Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan 1;371(6524):79-82.
doi: 10.1126/science.abe1916. Epub 2020 Nov 11.

Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors

Affiliations

Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors

Sophie Uyoga et al. Science. .

Abstract

The spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Africa is poorly described. The first case of SARS-CoV-2 in Kenya was reported on 12 March 2020, and an overwhelming number of cases and deaths were expected, but by 31 July 2020, there were only 20,636 cases and 341 deaths. However, the extent of SARS-CoV-2 exposure in the community remains unknown. We determined the prevalence of anti-SARS-CoV-2 immunoglobulin G among blood donors in Kenya in April-June 2020. Crude seroprevalence was 5.6% (174 of 3098). Population-weighted, test-performance-adjusted national seroprevalence was 4.3% (95% confidence interval, 2.9 to 5.8%) and was highest in urban counties Mombasa (8.0%), Nairobi (7.3%), and Kisumu (5.5%). SARS-CoV-2 exposure is more extensive than indicated by case-based surveillance, and these results will help guide the pandemic response in Kenya and across Africa.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1. Participant flow diagram for SARS-CoV-2 seroprevalence study of blood donors in Kenya.
Exclusion criteria for the selection of samples with complete data.
Fig. 2
Fig. 2. Timeline of sampling for SARS-CoV-2 seroprevalence in blood donors in Kenya.
(A to C) Against the timeline of the sampling period, (A) is the weekly crude seroprevalence and 95% confidence interval, (B) is the daily frequency of samples collected, and (C) is the temporal distribution of samples by region. Shown are the proportion, counts, and regional distribution of donors during the study period.

Comment in

References

    1. United Nations Department of Economic and Social Affairs Population Division, “World Urbanization Prospects: The 2018 Revision,” custom data acquired via (2018); https://population.un.org/wup/DataQuery.
    1. Africa Centres for Diseases Control and Prevention, “Coronavirus Disease 2019 (COVID-19)” (2020); https://africacdc.org/covid-19[accessed 21 July 2020].
    1. Diop B. Z., Ngom M., Pougué Biyong C., Pougué Biyong J. N., The relatively young and rural population may limit the spread and severity of COVID-19 in Africa: A modelling study. BMJ Glob. Health 5, e002699 (2020). 10.1136/bmjgh-2020-002699 - DOI - PMC - PubMed
    1. Dowd J. B., Andriano L., Brazel D. M., Rotondi V., Block P., Ding X., Liu Y., Mills M. C., Demographic science aids in understanding the spread and fatality rates of COVID-19. Proc. Natl. Acad. Sci. U.S.A. 117, 9696–9698 (2020). 10.1073/pnas.2004911117 - DOI - PMC - PubMed
    1. Ministry of Health Kenya, “Press Statement on the update of the coronavirus in the country and response measures” (2020); www.health.go.ke/wp-content/uploads/2020/03/Coronavirus-Press-Statement-....

Publication types